Journal of Cachexia Sarcopenia and Muscle-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2025-02-14 ms2000000318297836 来自安徽省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：废用性萎缩;咬肌;脂肪沉积
经验分享：JCSM投稿时间线：
2024.12.14 投 submitted to journal
2025.1.5 with editor
2025.1.13 under review
2025.1.31 Required Reviews Completed
2025.2.11 Decision in Process
待更新。。。

23 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2024-11-20 ms3000001983661864 来自北京

审稿速度:24.0 | 投稿命中率:25.0
偏重的研究方向：肌萎缩
经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月

72 69 举报

展开69条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2025-02-17 决战来自湖北省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：DIP中，等待。。。

14 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2025-03-06 1467de12m97暂无昵称来自江苏省

审稿速度:3.0
偏重的研究方向：低肌肉质量;临床
经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择

23 14 举报

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2025-04-04 ms4000000681775086 来自伊朗

审稿速度:24.0 | 投稿命中率:25.0
经验分享：WITH EDI 两个月打卡

16 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2025-04-01 ms4000000681775086 来自澳大利亚

审稿速度:12.0 | 投稿命中率:25.0
经验分享：从2.24 with editor到现在，乌鱼子

21 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2025-01-03 ms1000002013946887 来自浙江省

20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关

29 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2025-02-16 ms5000002977722150 来自上海

审稿速度:6.0 | 投稿命中率:25.0
经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。
该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。
接受的文章类型包括原创文章、评论、社论、会议报告等内容。
该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。
老年医学、肌肉减少症和恶病质研究的可以尝试一下。

17 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2024-08-05 1467de12m97暂无昵称来自江苏省

偏重的研究方向：低肌肉质量;临床
经验分享：记录一下，8月2号投的，现在是 submit to journal

78 14 举报

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251867, encodeId=53f1225186ed4, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：废用性萎缩;咬肌;脂肪沉积 经验分享：JCSM投稿时间线： 2024.12.14 投 submitted to journal 2025.1.5 with editor 2025.1.13 under review 2025.1.31 Required Reviews Completed 2025.2.11 Decision in Process 待更新。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61379298030, createdName=ms2000000318297836, createdTime=Fri Feb 14 10:07:07 CST 2025, time=2025-02-14, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2237908, encodeId=9555223e90817, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌萎缩 经验分享：9.28投，10.10 with editor ，10.27催了，10.28回复在找审稿人，10.30又with editor 现在11.20 还是with editor什么情况。。。。到底要多久啊。。即将两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba1a8284909, createdName=ms3000001983661864, createdTime=Wed Nov 20 00:08:49 CST 2024, time=2024-11-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2252377, encodeId=314522523e77d, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：DIP中，等待。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=22ec5549526, createdName=决战, createdTime=Mon Feb 17 17:03:29 CST 2025, time=2025-02-17, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2254928, encodeId=7f6d22549280b, content=审稿速度:3.0 偏重的研究方向：低肌肉质量;临床 经验分享：记录一下时间线2024年8月2日投稿 with editor 至9月2日催稿，9月4日回复找审稿人，9月16开始under review 10月18日大修。12月11日修回with editor直到2025年1月5日 underreview 1月31日给了大修（两个接受，一个不认可立项依据提了五个comment），2月21日修回目前在with editor。感觉期刊很严谨和慢，不焦虑的我已经开始焦虑了，毕业党谨慎选择, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Thu Mar 06 20:39:42 CST 2025, time=2025-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2259087, encodeId=3c38225908e90, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：WITH EDI 两个月打卡, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Fri Apr 04 11:15:13 CST 2025, time=2025-04-04, status=1, ipAttribution=伊朗), GetPortalCommentsPageByObjectIdResponse(id=2258664, encodeId=af512258664f8, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：从2.24 with editor到现在，乌鱼子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0f86442273, createdName=ms4000000681775086, createdTime=Tue Apr 01 13:03:01 CST 2025, time=2025-04-01, status=1, ipAttribution=澳大利亚), GetPortalCommentsPageByObjectIdResponse(id=2246409, encodeId=1bbd22464091a, content=20241219投的，到今天一直是Submitted to Journal，不知道是否和圣诞节假期有关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=289b6403146, createdName=ms1000002013946887, createdTime=Fri Jan 03 19:51:38 CST 2025, time=2025-01-03, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2252255, encodeId=87622252255f5, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：该期刊的审稿周期通常为16周左右，但是文章一旦被接受，通常会在4-8个月内完成发表。 该期刊主要关注与恶病质、肌肉减少症、肌肉萎缩、慢性病、晚期疾病、癌症、艾滋病、慢性心力衰竭、慢性肺病、肝硬化、慢性肾功能衰竭、类风湿关节炎、脂肪组织衰竭、老化过程、代谢综合征等相关的研究。 接受的文章类型包括原创文章、评论、社论、会议报告等内容。 该期刊为开放获取期刊，发表论文需支付版面费。整体来看，审稿周期有些长，录用率较低，自引率较高，近年来自引率保持在12.5%左右。 老年医学、肌肉减少症和恶病质研究的可以尝试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Sun Feb 16 22:58:14 CST 2025, time=2025-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省)]

2024-08-13 柒1111111111 来自江苏省

偏重的研究方向：肌肉减少症
经验分享：8.13号完成投递，记录一下

81 16 举报

展开16条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务